Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Gutmann

Showing results (81-90 of 434) with videos related to

Pageof 44
Sort By:
Neuro-Oncology|August 29, 2014
The mTOR signaling pathway as a treatment target for intracranial neoplasmsDoreen Pachow, Wolfgang Wick, David H Gutmann, et al.
Genes & Development|August 15, 2015
Neurofibromatosis-1 regulation of neural stem cell proliferation and multilineage differentiation operates through distinct RAS effector pathwaysYi-Hsien Chen, Scott M Gianino, David H Gutmann
Cancer Epidemiology|March 29, 2016
Peri-gestational risk factors for pediatric brain tumors in Neurofibromatosis Type 1Kimberly J Johnson, Nancy L Zoellner, David H Gutmann
Journal of Child Neurology|September 2, 2016
Macrocephaly Is Not a Predictor of Optic Pathway Glioma Development or Treatment in Neurofibromatosis Type 1Stephanie M Morris, Courtney L Monroe, David H Gutmann
Journal of Attention Disorders|February 23, 2012
A neuropsychological perspective on attention problems in neurofibromatosis type 1Alexandra K Templer, Jeffrey B Titus, David H Gutmann
The Journal of Clinical Investigation|April 6, 2006
Harnessing preclinical mouse models to inform human clinical cancer trialsDavid H Gutmann, Kim Hunter-Schaedle, Kevin M Shannon
Cancer Research|January 7, 2006
Mouse Models of Human Cancers Consortium Workshop on Nervous System TumorsDavid H Gutmann, Elizabeth A Maher, Terry Van Dyke
Cancer Research|January 25, 2005
Glioma formation in neurofibromatosis 1 reflects preferential activation of K-RAS in astrocytesBiplab Dasgupta, Wen Li, Arie Perry, et al.
The Journal of Investigative Dermatology|March 11, 2004
Piebaldism and neurofibromatosis type 1: horses of very different colorsRichard A Spritz, Peter H Itin, David H Gutmann
Cancer Cell|July 14, 2012
Innate neural stem cell heterogeneity determines the patterning of glioma formation in childrenDa Yong Lee, Scott M Gianino, David H Gutmann
Pageof 44

Showing results (81-90 of 434) with videos related to

Sort By:
Pageof 44
Neuro-Oncology|August 29, 2014
The mTOR signaling pathway as a treatment target for intracranial neoplasmsDoreen Pachow, Wolfgang Wick, David H Gutmann, et al.
Genes & Development|August 15, 2015
Neurofibromatosis-1 regulation of neural stem cell proliferation and multilineage differentiation operates through distinct RAS effector pathwaysYi-Hsien Chen, Scott M Gianino, David H Gutmann
Cancer Epidemiology|March 29, 2016
Peri-gestational risk factors for pediatric brain tumors in Neurofibromatosis Type 1Kimberly J Johnson, Nancy L Zoellner, David H Gutmann
Journal of Child Neurology|September 2, 2016
Macrocephaly Is Not a Predictor of Optic Pathway Glioma Development or Treatment in Neurofibromatosis Type 1Stephanie M Morris, Courtney L Monroe, David H Gutmann
Journal of Attention Disorders|February 23, 2012
A neuropsychological perspective on attention problems in neurofibromatosis type 1Alexandra K Templer, Jeffrey B Titus, David H Gutmann
The Journal of Clinical Investigation|April 6, 2006
Harnessing preclinical mouse models to inform human clinical cancer trialsDavid H Gutmann, Kim Hunter-Schaedle, Kevin M Shannon
Cancer Research|January 7, 2006
Mouse Models of Human Cancers Consortium Workshop on Nervous System TumorsDavid H Gutmann, Elizabeth A Maher, Terry Van Dyke
Cancer Research|January 25, 2005
Glioma formation in neurofibromatosis 1 reflects preferential activation of K-RAS in astrocytesBiplab Dasgupta, Wen Li, Arie Perry, et al.
The Journal of Investigative Dermatology|March 11, 2004
Piebaldism and neurofibromatosis type 1: horses of very different colorsRichard A Spritz, Peter H Itin, David H Gutmann
Cancer Cell|July 14, 2012
Innate neural stem cell heterogeneity determines the patterning of glioma formation in childrenDa Yong Lee, Scott M Gianino, David H Gutmann
Pageof 44